Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

  • Showing results for a modified search because your search retrieved no results.
1.

Plasma polychlorinated biphenyl concentrations and immune function in postmenopausal women.

Spector JT, De Roos AJ, Ulrich CM, Sheppard L, Sjödin A, Wener MH, Wood B, McTiernan A.

Environ Res. 2014 May;131:174-80. doi: 10.1016/j.envres.2014.03.011. Epub 2014 Apr 11.

2.

CD226 protein is involved in immune synapse formation and triggers Natural Killer (NK) cell activation via its first extracellular domain.

Hou S, Ge K, Zheng X, Wei H, Sun R, Tian Z.

J Biol Chem. 2014 Mar 7;289(10):6969-77. doi: 10.1074/jbc.M113.498253. Epub 2014 Jan 22.

3.

The impact of sleep complaints on physical health and immune outcomes in rescue workers: a 1-year prospective study.

Irish LA, Dougall AL, Delahanty DL, Hall MH.

Psychosom Med. 2013 Feb;75(2):196-201. doi: 10.1097/PSY.0b013e31827d85ab. Epub 2013 Jan 16.

4.

Enhanced function of redirected human T cells expressing linker for activation of T cells that is resistant to ubiquitylation.

Kunii N, Zhao Y, Jiang S, Liu X, Scholler J, Balagopalan L, Samelson LE, Milone MC, June CH.

Hum Gene Ther. 2013 Jan;24(1):27-37. doi: 10.1089/hum.2012.130. Epub 2012 Nov 6.

5.

TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.

Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z, Wei H.

PLoS Pathog. 2012;8(3):e1002594. doi: 10.1371/journal.ppat.1002594. Epub 2012 Mar 15.

6.

Immune activation by combination human lymphokine-activated killer and dendritic cell therapy.

West EJ, Scott KJ, Jennings VA, Melcher AA.

Br J Cancer. 2011 Sep 6;105(6):787-95. doi: 10.1038/bjc.2011.290. Epub 2011 Aug 16.

7.

Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1.

Szczepanski MJ, Szajnik M, Welsh A, Whiteside TL, Boyiadzis M.

Haematologica. 2011 Sep;96(9):1302-9. doi: 10.3324/haematol.2010.039743. Epub 2011 May 23.

8.

TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets.

Heidemann SC, Chavez V, Landers CJ, Kucharzik T, Prehn JL, Targan SR.

J Clin Immunol. 2010 Jul;30(4):531-8. doi: 10.1007/s10875-010-9382-9. Epub 2010 Mar 27.

9.

Suppression of natural killer cell cytotoxicity in postpartum women.

Groer M, El-Badri N, Djeu J, Harrington M, Van Eepoel J.

Am J Reprod Immunol. 2010 Mar 1;63(3):209-13. doi: 10.1111/j.1600-0897.2009.00788.x. Epub 2010 Jan 5.

10.

Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells.

Watchmaker PB, Berk E, Muthuswamy R, Mailliard RB, Urban JA, Kirkwood JM, Kalinski P.

J Immunol. 2010 Jan 15;184(2):591-7. doi: 10.4049/jimmunol.0902062. Epub 2009 Dec 16.

11.

LFA-1 and CD2 synergize for the Erk1/2 activation in the Natural Killer (NK) cell immunological synapse.

Zheng X, Wang Y, Wei H, Sun R, Tian Z.

J Biol Chem. 2009 Aug 7;284(32):21280-7. doi: 10.1074/jbc.M807053200. Epub 2009 Jun 4.

12.

Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.

Evans DL, Lynch KG, Benton T, Dubé B, Gettes DR, Tustin NB, Lai JP, Metzger D, Douglas SD.

Biol Psychiatry. 2008 May 1;63(9):899-905. Epub 2007 Oct 22.

13.

Protective efficacy of a DNA influenza virus vaccine is markedly increased by the coadministration of a Schiff base-forming drug.

Charo J, Lindencrona JA, Carlson LM, Hinkula J, Kiessling R.

J Virol. 2004 Oct;78(20):11321-6.

14.

Supplemental Content

Support Center